Committed to sharing our science

Committed to sharing our science

374 results available

Aficamten is Safe and Effective in Obstructive Hypertrophic Cardiomyopathy With Comorbidities Obesity, Hypertension and Diabetes: A SEQUOIA-HCM Sub-study

Poster, AHA 2025

Lee, MMY et al.

November 8, 2025
Improvement in Echo Measures of Diastolic Function Reflects Improved Exercise Performance in Obstructive Hypertrophic Cardiomyopathy: Insights From the SEQUOIA-HCM Trial

Poster, AHA 2025

Lu, H et al.

November 8, 2025
Outcomes Following Septal Myectomy in Pediatric and Young Patients with Obstructive Hypertrophic Cardiomyopathy

Poster, HCMS 2025

Kamna, D et al.

November 7, 2025
Effects of Aficamten vs Metoprolol on Patient-Reported Health Status in Obstructive HCM

Oral Presentation, HCMS 2025

Nassif, ME et al.

November 7, 2025
Effect of Aficamten vs Metoprolol on Patient-Reported Health Status in Obstructive Hypertrophic Cardiomyopathy

Journal of the American College of Cardiology

Nassif, ME et al.

November 7, 2025